- Advertisement -
Long Grove Pharmaceuticals president Peter J. Karas said by combining its quality pharmaceuticals with Optiscan’s advanced imaging, the company was poised to deliver real innovation and improve outcomes across healthcare.Optiscan management said the deal showed an increasing number of…
Click here to view the original article.
